At the virtual spring conference of the National Association of ACOs (NAACOS), policy officials highlighted the changes since the start of the year due to coronavirus disease 2019 (COVID-19).
Due to the chaos created by the spread of coronavirus disease 2019 (COVID-19), most of Congress’ time this year has been taken up by relief legislation, and the upcoming election season will leave little time to advocate for other measures of interest to accountable care organizations (ACOs), said officials of the National Association of ACOs (NAACOS) at their annual spring meeting Wednesday.
In a virtual session providing policy updates, Allison Brennan, MPP, senior vice president of government affairs for the organization, said it is still very much interested in seeking relief for rural ACOs through S 2648, the Rural ACO Improvement Act. The bill amends title XVIII of the Social Security Act to change the benchmarking process for the Medicare Shared Savings Program (MSSP) to ensure that all ACOs have an equal opportunity to share in savings regardless of their geographic location.
The president has signed 4 stimulus bills totaling $3 trillion in spending aimed at providing assistance to health care providers, hospitals, and systems, as well as new flexibilities around telehealth and substance use disorder (SUD).
Brennan noted that the Coronavirus Aid, Relief, and Economic Security Act included changes to federal law governing confidentiality of SUD records to ease the ability of health care providers to share, with patient consent, protected information specific to SUD. That has been a priority of NAACOS, she said.
In addition, Brennan said the organization was pleased by an “inaction”—NAACOS did not want CMS to accept a recommendation from the Medicare Payment Advisory Commission (MedPAC) that ACOs not attempt to reconcile spending and benchmarks for performance in 2020, given the COVID-19 operating environment. The organization wanted to retain the ability for ACOs that will manage to achieve shared savings to keep them, while protecting ACOs facing losses, she said.
However, CMS, through its Center for Medicare and Medicaid Innovation, delayed the start of its direct contracting model, which was another MedPAC request.
Despite the pandemic and its complications, Brennan said the shift to value-based care will continue.
Jennifer Gasperini, a NAACOS senior policy advisor, said NAACOS is continuing to advocate for continued changes to the triggering of CMS’ “extreme and uncontrollable circumstances” policy for the MSSP; the changes, some of which remove some costs related to COVID-19 from MSSP expenditures, are good but do not go far enough, she said.
“This is the start, not the end of this process,” she said.
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More
Need for Pharmacogenomic Testing in Mental Health Care Explored at AMCP 2024
April 17th 2024Presenters from Mayo Clinic discussed the benefits of implementing pharmacogenomic testing in mental health care for the betterment of patient outcomes, reducing medical costs, and more at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting.
Read More